# US 2016/0354588 A1 · Dynamic therapy delivery system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354588 A1
- Document ID: US20160354588A1
- Status: Published application
- Kind: A1
- Application number: 15/237,742
- Filed: 2016-08-16
- Published: 2016-12-08
- Earliest claimed: 2013-02-07
- Assignees: Hill-Rom Services, Inc.
- Applicants: Hill-Rom Services, Inc.
- Inventors: David L Ribble; Laetitia Gazagnes; Charles A. Lachenbruch
- Web page: https://patentgrep.com/patent/US20160354588A1

## CPC

- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A47C 27/081: {of pneumatic type}
- A61B 5/4839: {combined with drug delivery}
- A61B 5/6892: {Mats}
- A61G 7/047: Beds for special sanitary purposes {, e.g. for giving enemas, irrigations, flushings (A61G7/02 takes precedence; means for bathing bed-ridden persons A61G7/0005)}
- A61M 2205/18: with alarm
- A61M 2205/3303: Using a biosensor
- A61M 2205/3317: Electromagnetic, inductive or dielectric measuring means
- A61M 2205/3561: local, e.g. within room or hospital
- A61M 2205/75: with filters
- A61M 2230/005: Parameter used as control input for the apparatus
- A61M 2230/20: Blood composition characteristics
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A47C: CHAIRS; SOFAS; BEDS
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61G: TRANSPORT, PERSONAL CONVEYANCES OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS (appliances for aiding patients or disabled persons to walk A61H3/00); OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES (embalming corpses A01N1/00)

## Abstract

Systems for delivery of therapeutic agents and related methods are disclosed. A sensing system is configured to detect a chemical in the vicinity of a patient and transmit a signal to a controller upon detection. A controller is configured to release a therapeutic agent which is transported to the site of interest. The controller communicates with an electronic medical records database, an alarm and a nurse call system.

## Claims

### Claim at position 1

-20. (canceled)

### Claim 21

A therapy delivery patch comprising
a filter sheet for placement adjacent a patient's skin,
an adhesive layer extending outwardly from the filter sheet and configured to attach to the patient's skin,
a cover forming a space above the filter sheet,
a therapeutic agent repository situated within the space,
a flow controller situated within the space and operable to control a flow of therapeutic agent from the therapeutic agent repository through the filter sheet onto the patient's skin.

### Claim 22 (depends on 21)

The therapy delivery patch of claim 21, wherein the flow controller is situated between the therapeutic agent repository and the filter sheet.

### Claim 23 (depends on 22)

The therapy delivery patch of claim 22, wherein the flow controller comprises a valve.

### Claim 24 (depends on 22)

The therapy delivery patch of claim 22, wherein the flow controller comprises a microfluidic pump.

### Claim 25 (depends on 21)

The therapy delivery patch of claim 21, further comprising a processor situated in the space, the processor being configured to operate the flow controller to control the flow of therapeutic agent.

### Claim 26 (depends on 25)

The therapy delivery patch of claim 25, further comprising at least one sensor that detects a chemical secretion of the patient.

### Claim 27 (depends on 26)

The therapy delivery patch of claim 26, wherein the processor operates the flow controller to control the flow of therapeutic agent based on a signal received from the at least one sensor.

### Claim 28 (depends on 26)

The therapy delivery patch of claim 26, wherein the at least one sensor extends through the filter sheet.

### Claim 29 (depends on 26)

The therapy delivery patch of claim 26, wherein the at least one sensor is situated between the flow controller and the patient's skin.

### Claim 30 (depends on 26)

The therapy delivery patch of claim 26, wherein the at least one sensor comprises one or more of the following: a metal oxide type semi-conductor (MOS) sensor, a capacitive sensor, an inductive sensor or a surface acoustic wave sensor.

### Claim 31 (depends on 26)

The therapy delivery patch of claim 26, wherein the at least one sensor comprises a protein based biosensor.

### Claim 32 (depends on 31)

The therapy delivery patch of claim 31, wherein the protein based biosensor comprises one or more of the following: an odarant binding protein (OBP), a sensory appendage protein (SAP), an odorant receptor, a gustatory receptor, a serpentine receptor, or an odarant degrading enzyme (ODE).

### Claim 33 (depends on 31)

The therapy deliver patch of claim 31, wherein the at least one sensor further comprises an electrochemical transducer to generate an electrical signal in response to detection of a chemical by the protein based biosensor.

### Claim 34 (depends on 26)

The therapy delivery patch of claim 26, wherein the at least one sensor detects an indication of Ischemia by detecting any one or more of the following: CO2, Urea, Urate, Chloride, Lactic Acid, CO2/O2 or O2.

### Claim 35 (depends on 26)

The therapy delivery patch of claim 26, wherein the at least one sensor detects a 1L-1α and Creatine Phosphokinase (CPK) which is indicative of wound development.

### Claim 36 (depends on 21)

The therapy delivery patch of claim 21, wherein the therapeutic agent comprises a vasodilator.

### Claim 37 (depends on 36)

The therapy delivery patch of claim 36, wherein the vasodilator comprises one or more of the following: histamine, niacin, potassium or nitric acid.

### Claim 38 (depends on 21)

The therapy delivery patch of claim 21, wherein the cover forms a dome over the filter sheet.

### Claim 39 (depends on 38)

The therapy delivery patch of claim 38, wherein a bottom of the dome is located near a junction between the adhesive layer and the filter sheet.

### Claim 40 (depends on 38)

The therapy delivery patch of claim 38, wherein the therapeutic agent repository is situated between the flow controller and a top of the dome.
